Sign up Australia
Proactive Investors - Run By Investors For Investors

ResApp Health the leading ASX % Faller in morning trade on big volume

ResApp has traded over 90 mln shares by 11:30am this morning
ASX
The biggest % fallers on the ASX this morning

ResApp Health Ltd's (ASX:RAP) shares have plunged 76% to $0.074 in the first 90 minutes of trade after the company reported preliminary top-line results from the SMARTCOUGH-C Study.

The study is for the diagnosis of childhood respiratory disease using cough sounds.

Analysis of the SMARTCOUGH-C study data revealed many issues in the quality of cough recordings and that many patients were treated before their coughs were recorded.

ResApp intends to continue its Australian adult programme in parallel and initiate a US adult clinical study this US winter.

Company Name Code Last Change Volume
ResApp Health Ltd RAP $0.070 -77.42% 79,370,373
Jacka Resources Ltd JKA $0.003 -25% 22,600
Latin Resources Ltd LRS $0.004 -20% 3,423,002
Uranium Equities Ltd UEQ $0.005 -16.67% 610,000
Memphasys Ltd MEM $0.005 -16.67% 3,478,010
Eclipse Metals Ltd EPM $0.005 -16.67% 150,000
Hastings Technology Metals Ltd HAS $0.160 -15.79% 284,061
SportsHero Ltd SHO $0.032 -15.79% 50,000
Cohiba Mining CHK $0.011 -15.39% 1,750,880
Aruma Resources Ltd AAJ $0.006 -14.29% 120,000

 





Register here to be notified of future . Company articles
View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

1505911280_social-media.jpg
September 20 2017
The Cello Health unit led the way as it grew organically and via the acquisition
picture of Hunger Games cast
November 27 2017
Some of the most famous films ever made have been backed by FFI since it was founded in 1950
Laptop screen with graphs
August 04 2017
Total revenues for the six months to 30 June grew by 5%, with Ebiquity adding it remains confident in hitting its operating profits and earnings targets for the rest of the year

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use